| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 64.32M | 66.13M | 60.48M | 57.04M | 45.79M | 40.29M |
| Gross Profit | 20.34M | 20.87M | 19.17M | 18.16M | 13.36M | 13.88M |
| EBITDA | 11.27M | 14.50M | 15.06M | 10.64M | 8.07M | 8.69M |
| Net Income | 201.32K | 5.02M | 3.43M | 4.54M | 2.86M | 4.26M |
Balance Sheet | ||||||
| Total Assets | 72.78M | 78.62M | 71.46M | 64.98M | 51.01M | 37.82M |
| Cash, Cash Equivalents and Short-Term Investments | 14.43M | 15.67M | 26.84M | 24.68M | 23.91M | 12.74M |
| Total Debt | 11.95M | 15.13M | 15.52M | 10.47M | 3.97M | 5.67M |
| Total Liabilities | 19.71M | 23.98M | 21.87M | 18.83M | 10.32M | 12.74M |
| Stockholders Equity | 52.12M | 53.68M | 48.65M | 45.22M | 40.69M | 25.08M |
Cash Flow | ||||||
| Free Cash Flow | -7.77M | -4.08M | 9.05M | 4.07M | 4.45M | 8.18M |
| Operating Cash Flow | 8.36M | 13.02M | 14.00M | 6.65M | 5.11M | 8.33M |
| Investing Cash Flow | -18.02M | -12.48M | 7.04M | -16.42M | -3.53M | -311.47K |
| Financing Cash Flow | -8.88M | -8.86M | -8.56M | -3.81M | 9.59M | -6.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$222.36M | 3.17 | 11.37% | ― | 20.41% | 188.08% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | HK$225.00M | 200.00 | 0.37% | ― | 8.43% | -94.67% | |
59 Neutral | HK$493.33M | -14.52 | -18.78% | ― | -8.26% | -240.93% | |
49 Neutral | HK$5.62B | 4,680.00 | 1.30% | ― | 78.48% | -33.33% | |
49 Neutral | HK$152.25M | 34.09 | 0.63% | ― | -78.51% | 388.89% |
Legion Consortium Limited has announced the composition of its board of directors, highlighting the roles and functions of each member. This update includes the designation of executive and independent non-executive directors, as well as their specific roles within the company’s audit, nomination, and remuneration committees. This announcement may impact the company’s governance structure and provide clarity on leadership roles, potentially influencing stakeholder confidence and the company’s strategic direction.
The most recent analyst rating on (HK:2129) stock is a Hold with a HK$0.18 price target. To see the full list of analyst forecasts on Legion Consortium Limited stock, see the HK:2129 Stock Forecast page.
Legion Consortium Limited has adopted new terms of reference for its Nomination Committee, which were approved by the Board of Directors. The committee is tasked with developing and reviewing the nomination policy, assessing the board’s structure and diversity, and identifying qualified individuals for board membership. This move aims to enhance the company’s corporate governance practices and align its board composition with strategic goals.
The most recent analyst rating on (HK:2129) stock is a Hold with a HK$0.18 price target. To see the full list of analyst forecasts on Legion Consortium Limited stock, see the HK:2129 Stock Forecast page.
Legion Consortium Limited has announced the appointment of Ms. Tham Chia Sze as a member of its Nomination Committee, effective December 11, 2025. This move is in response to recent amendments to the Listing Rules and Corporate Governance Code, aiming to enhance the board’s effectiveness and diversity, thereby improving the company’s corporate governance practices.
The most recent analyst rating on (HK:2129) stock is a Hold with a HK$0.18 price target. To see the full list of analyst forecasts on Legion Consortium Limited stock, see the HK:2129 Stock Forecast page.
Legion Consortium Limited has announced the renewal of its continuing connected transactions with R&S Engineering and JH Tyres & Batteries through new master services agreements effective from January 2026 to December 2028. These agreements, which involve the provision of repair, maintenance, and tyre services for the company’s vehicle fleet, are significant as they ensure the continuation of essential services while adhering to Hong Kong’s Listing Rules. The transactions are subject to reporting and annual review requirements but are exempt from circular and shareholders’ approval due to their aggregated consideration being below the HK$10,000,000 threshold.
The most recent analyst rating on (HK:2129) stock is a Hold with a HK$0.13 price target. To see the full list of analyst forecasts on Legion Consortium Limited stock, see the HK:2129 Stock Forecast page.
Legion Consortium Limited has announced a change in its company secretary, authorized representatives, and process agent in Hong Kong. Mr. Man Yun Wah has ceased his roles, and Ms. Wong Po Lam, with 13 years of experience in financial reporting and corporate compliance, has been appointed as his replacement. The company experienced a brief period of non-compliance with the Hong Kong Stock Exchange’s listing rules due to the vacancy but has since rectified the situation and aims to enhance its governance procedures.
The most recent analyst rating on (HK:2129) stock is a Hold with a HK$0.13 price target. To see the full list of analyst forecasts on Legion Consortium Limited stock, see the HK:2129 Stock Forecast page.
Legion Consortium Limited, a company incorporated in the Cayman Islands, has announced a change in its principal place of business in Hong Kong. Effective from November 28, 2025, the company will relocate to Room 1910, 19/F., C C Wu Building, 302-308 Hennessy Road, Wan Chai, Hong Kong. This move may signify strategic positioning or operational adjustments within the region.
The most recent analyst rating on (HK:2129) stock is a Hold with a HK$0.13 price target. To see the full list of analyst forecasts on Legion Consortium Limited stock, see the HK:2129 Stock Forecast page.